201204FDA监品种.docVIP

From Medscape Medical News FDA Puts 16 Drugs on Watch List Robert Lowes Authors and Disclosures processing.... ? April 17, 2012 — The US Food and Drug Administration (FDA) today issued its latest quarterly list of drugs to monitor after having identified potential signs of serious risks or new safety information in the agencys Adverse Event Reporting System (AERS) database during the last 3 months of 2011. The 16 drugs on the list include milnacipran (Savella, Forest Pharmaceuticals), a drug for managing fibromyalgia, with a potential safety issue of homicidal ideation as identified t